|
The device was not returned for evaluation.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.The investigation determined that the reported difficulty advancing the device and balloon rupture appear to be related to operational context.There was no leak noted during preparation or during the first inflation, which suggests a product quality issue did not contribute to the reported difficulties.It was reported by the account that the balloon dilatation catheter (bdc) interacted with the mildly tortuous, heavily calcified and 90% stenosed lesion resulting in the reported difficulty advancing the device and subsequently the balloon became damaged and ruptured during the second inflation.Based on the reported information, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
|
It was reported that the procedure was to treat a 90% stenosed de novo lesion in the left anterior descending (lad) artery with heavy calcification and mild tortuosity.The 3x8mm nc trek neo balloon dilatation catheter was advanced to the target lesion with resistance due to the anatomy.The balloon of the bdc was inflated; however, the balloon ruptured during the second inflation at 14 atmospheres (atm).Therefore, the bdc was removed from the patient.A non-abbott balloon was used to continue the procedure.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information was provided.
|